| Line item | 2025-04-30 FY | 2024-04-30 FY | 2023-04-30 FY | 2022-04-30 FY |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | – | – |
| Operating Expenses | – | – | – | – |
| R&D | – | – | – | – |
| SG&A | $24.28M | $16.89M | $13.99M | $20.18M |
| Operating Income | – | – | – | – |
| Interest Expense | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.85M | -$15.95M | -$13.59M | -$15.27M |
| EPS (basic) | -0.0300 | -0.0800 | -0.0800 | – |
| EPS (diluted) | -0.0300 | -0.0800 | -0.0800 | -0.1100 |
| Shares (diluted) | $267.33M | $212.05M | $172.20M | – |